Trial Profile
HepNet Pilot Trial: Multicenter Trial for the Treatment of Chronic Hepatitis E With Sofosbuvir (SofE)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Jun 2023
Price :
$35
*
At a glance
- Drugs Sofosbuvir (Primary)
- Indications Hepatitis E
- Focus Therapeutic Use
- Acronyms HepNet Pilot Trial; HepNet-SofE study
- 20 Jun 2023 Results evaluating the changes in Chronic hepatitis E virus (HEV) intra-host populations during sofosbuvir treatment, published in the Hepatology.
- 07 Mar 2019 Status changed from active, no longer recruiting to completed.
- 06 Dec 2018 Status changed from recruiting to active, no longer recruiting.